iMed Group is a private held company created with the objective of filling the very specific and special medical needs of a small population of adults and children seeking life-preserving therapeutics for rare diseases.

Following the leadership of our partners around the world and under the management of a highly experienced team, iMed Group pursues the objective of becoming the leader biopharmaceutical research company in Latin America .

The company is currently seeking strategic alliances and dedicated to acquiring, developing, registering and marketing high medical value specialty medicines.